A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine

Roche logo

Roche

Status

Completed

Conditions

Diabetes Mellitus Type 1

Treatments

Device: Insulin pumps

Study type

Interventional

Funder types

Industry

Identifiers

NCT00468754
RD000000275
RD000275

Details and patient eligibility

About

This trial will compare the metabolic control in type 1 diabetes obtained by continuous infusion of insulin lispro with that obtained by multiple daily injections of insulin lispro and glargine, a long-acting insulin analogue. Patients will be switched to the alternative treatment after 4 months. Glucose variability in the last month of each treatment will be analyzed.

Enrollment

50 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 1 diabetic patients, 18-60 years of age
  • Diabetic for >2 years
  • Treated with CSII for >=6 months
  • HbA1c <8.5%

Exclusion criteria

  • Treatment with daily insulin injections
  • Inability to handle pump therapy
  • Untreated retinopathy

Trial design

50 participants in 2 patient groups

A
Experimental group
Treatment:
Device: Insulin pumps
B
Experimental group
Treatment:
Device: Insulin pumps

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems